PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA3CT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $20,892
Award facts
- Contract value 100% obligated
- $20,891.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,891.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 29, 2025, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. AmerisourceBergen holds a $999,999,999.00 prime IDC (designated SPE2DX) running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies.
AmerisourceBergen's contract portfolio with the federal government demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management pharmaceuticals, and antibiotics. The company's competitive award history reflects its ability to meet federal procurement requirements through open competition. The DLA Medical Supply Chain's reliance on AmerisourceBergen as a prime vendor underscores the company's strategic importance to supporting military healthcare programs worldwide, with plans for the DLA to establish Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards among different contractors.
Quick answers
Who was awarded contract SPE2D826FA3CT?
SPE2D826FA3CT was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 29, 2025.
How much is contract SPE2D826FA3CT worth?
The government has obligated $20,892 on SPE2D826FA3CT.
Is contract SPE2D826FA3CT an order under another contract?
Yes. SPE2D826FA3CT is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA3CT competed?
The extent of competition for SPE2D826FA3CT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award